2012Hebei yixueRequires access

The Clinical Analysis of 74 Patients of Gastroesophageal Reflux Disease Treated by Rabeprazole and Mosapride

Xuedong Shen

Open publisher page 0 citations

Abstract

Objective: To explore the effects of gastroesophageal reflux disease treated by rabeprazole and mosapride.Method:150 patients of gastroesophageal reflux disease from Mar.2005 to Mar.2011 were randomly divided into two groups,the observation group(n=74),and the control group(n=76).The observation group were given rabeprazole and mosapride,and the control group were treated only with rabeprazole.Result:After two months treatment,the total effective rate in the observation group was 93.24%,significantly difference to the control group,with the rate of 81.58%(X2=4.61,P0.05).There was no obvious adverse effect.Conclusion: The treatment effect of gastroesophageal reflux disease treated by rabeprazole and mosapride would be remarkable,safe and reliable,which could apply in practice.

About this research paper

What this paper is about

Objective: To explore the effects of gastroesophageal reflux disease treated by rabeprazole and mosapride.Method:150 patients of gastroesophageal reflux disease from Mar.2005 to Mar.2011 were randomly divided into two groups,the observation group(n=74),and the control group(n=76).The observation group were given rabeprazole and mosapride,and the control group were treated only with rabeprazole.Result:After two months treatment,the total effective rate in the observation group was 93.24%,significantly difference to the control group,with the rate of 81.58%(X2=4.61,P0.05).There was no obvious adverse effect.Conclusion: The treatment effect of gastroesophageal reflux disease treated by rabeprazole and mosapride would be remarkable,safe and reliable,which could apply in practice.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective: To explore the effects of gastroesophageal reflux disease treated by rabeprazole and mosapride.Method:150 patients of gastroesophageal reflux disease from Mar.2005 to Mar.2011 were randomly divided into two groups,the observation group(n=74),and the control group(n=76).The observation group were given rabeprazole and mosapride,and the control group were treated only with rabeprazole.Result:After two months treatment,the total effective rate in the observation group was 93.24%,significantly difference to the control group,with the rate of 81.58%(X2=4.61,P0.05).There was no obvious adverse effect.Conclusion: The treatment effect of gastroesophageal reflux disease treated by rabeprazole and mosapride would be remarkable,safe and reliable,which could apply in practice.

Key concepts: Rabeprazole, Mosapride, Medicine, Reflux, Gastroenterology, Internal medicine, Disease, Helicobacter pylori

Related papers

Back to paper searchBrowse research topicsOriginal source
The Clinical Analysis of 74 Patients of Gastroesophageal Reflux Disease Treated by Rabeprazole and Mosapride — Research Paper | ScholarLens